While reporting financial results for the first quarter on Tuesday, Medtronic plc. raised its adjusted earnings guidance for the full-year 2020, while maintaining organic revenue growth outlook.
"As a result of our first quarter outperformance and confidence in our outlook, we are raising our full year EPS guidance," said Omar Ishrak, Medtronic chairman and chief executive officer.
For fiscal 2010, the company increased its adjusted earnings guidance to a new range of $5.54 to $5.60 per share from the prior range of $5.44 to $5.50 per share. This includes an estimated 10 cent negative impact from foreign exchange based on current rates.
However, the company continues to project organic revenue growth of about 4 percent. At current exchange rates, revenue growth would be negatively affected by 0.8 to 1.2 percent.
On average, analysts polled by Thomson Reuters expect the company to report earnings of $5.48 per share on revenue growth of 2.8 percent to $31.41 billion for the year. Analysts' estimates typically exclude special items.
For comments and feedback contact: firstname.lastname@example.org
美美敦力（Medtronic）董事长兼首席执行官奥马尔•伊斯赫克( Omar Ishrak )表示：“由于我们第一季度的表现优于预期，以及对我们前景的信心，我们正在提高我们全年的 EPS 指引。”
汤森路透( Thomson Reuters )调查的分析师平均预计，该公司今年营收增长2.8%，至31.41亿美元，每股收益为5.48美元。分析师的估计通常不包括特殊项目。
有关意见和反馈，请联系： edition @ rttnews.com